Overexpression of immunosuppressive cytokines is associated with poorer clinical stage of oral squamous cell carcinoma
| dc.creator | Diego Antonio Costa Arantes | |
| dc.creator | Nádia Lago Costa | |
| dc.creator | Elismauro Francisco Mendonça | |
| dc.creator | Tarcília Aparecida da Silva | |
| dc.creator | Aline Carvalho Batista | |
| dc.date.accessioned | 2025-03-27T20:32:37Z | |
| dc.date.accessioned | 2025-09-09T01:08:02Z | |
| dc.date.available | 2025-03-27T20:32:37Z | |
| dc.date.issued | 2016-01 | |
| dc.description.sponsorship | CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico | |
| dc.format.mimetype | ||
| dc.identifier.doi | https://doi.org/10.1016/j.archoralbio.2015.10.013 | |
| dc.identifier.issn | 1879-1506 | |
| dc.identifier.uri | https://hdl.handle.net/1843/81029 | |
| dc.language | eng | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Archives of Oral Biology | |
| dc.rights | Acesso Restrito | |
| dc.subject | Immune tolerance | |
| dc.subject | Interleukin-10 | |
| dc.subject | Mouth neoplasms | |
| dc.subject | Squamous cell carcinoma of head and neck | |
| dc.subject | Cytokines | |
| dc.subject | Proteins | |
| dc.subject | Mesenchymal stem cells | |
| dc.subject.other | Immunosuppression | |
| dc.subject.other | Interleukin-10 | |
| dc.subject.other | Oral cancer | |
| dc.subject.other | Oral squamous cell carcinoma | |
| dc.subject.other | Transforming growth factor β | |
| dc.title | Overexpression of immunosuppressive cytokines is associated with poorer clinical stage of oral squamous cell carcinoma | |
| dc.type | Artigo de periódico | |
| local.citation.epage | 35 | |
| local.citation.spage | 28 | |
| local.citation.volume | 61 | |
| local.description.resumo | Objective: The aim of this study was to evaluate the expression of IL-10 and TGF-β2 in oral squamous cell carcinoma (OSCC) and its relationship with prognostic clinical and microscopic parameters. Design: Immunohistochemistry was used to assess the expression of IL-10 and TGF-β2 in OSCC samples from 43 patients who had undergone surgical excision and neck dissection. Metastatic lymph nodes were included in the study (n=23). Samples of healthy oral mucosa (n=20) were used as controls. The sections were evaluated using a semi-quantitative method in conjunction with staining intensity. Results: Our findings showed that the expression of IL-10 and TGF-β2 by neoplastic and stromal cells was high in most of the OSCC samples (>70% of samples), especially when compared to the controls (≅10% of samples) (P<0.05). OSCC neoplastic cells in cervical lymph nodes were also positive for IL-10 and TGF-β2. An association between high expression of IL-10 by neoplastic cells and advanced clinical stage (T3-T4) was verified (P=0.02). Although not statistically significant, the expression of TGF-β2 was also augmented in advanced stage tumours. Conclusions: These data suggest that the ability of OSCC neoplastic cells to secrete immunosuppressive cytokines could contribute to clinical progression by maintaining a microenvironment conducive to evasion and tumour proliferation. | |
| local.identifier.orcid | https://orcid.org/0000-0002-1306-747X | |
| local.identifier.orcid | https://orcid.org/0000-0002-6751-3279 | |
| local.identifier.orcid | https://orcid.org/0000-0001-9623-7835 | |
| local.identifier.orcid | https://orcid.org/0000-0002-2117-5593 | |
| local.publisher.country | Brasil | |
| local.publisher.department | FAO - DEPARTAMENTO DE CLÍNICA | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://www.sciencedirect.com/science/article/pii/S0003996915300613?via%3Dihub |
Arquivos
Licença do pacote
1 - 1 de 1